You are using an outdated browser. Please upgrade your browser to improve your experience.

progressive supranuclear palsy

Disease Summary
Associated Targets (658)
Tbio

454

Tdark

99

Tchem

82

Tclin

23


Explore Associated Targets
Mondo Description Progressive supranuclear palsy (PSP) is a rare late-onset neurodegenerative disease characterized by supranuclear gaze palsy, postural instability, progressive rigidity, and mild dementia.
Disease Ontology Description A movement disease characterized by serious and progressive problems with control of gait and balance, along with complex eye movement and thinking problems. It involves gradual deterioration and death of specific volumes of the brain.
Mondo Term and Equivalent IDs
MONDO:0019037:  progressive supranuclear palsy
GARD:0007471: 
MESH:D013494: 
NCIT:C85028: 
Orphanet:683: 
SCTID:28978003: 
UMLS:C0038868: 
UMLS:CN205522: 
GWAS Targets (31)
Target
TDL
Study Count
SNP Count
Beta Count
Odds Ratio
Evidence (Mean Rank Score)
Provenance
Tclin
2
2
0
1.9
95.2
Tbio
2
2
0
1.9
95.2
Tclin
2
2
0
1.9
95.2
Tbio
2
2
0
1.9
95.2
Tclin
2
2
0
1.9
95.2
Target
TDL
Beta Count
Odds Ratio
Evidence (Mean Rank Score)
Provenance
Tclin
0
1.9
95.2
Tbio
0
1.9
95.2
Tclin
0
1.9
95.2
Tbio
0
1.9
95.2
Tclin
0
1.9
95.2
Disease Hierarchy
Target Novelty (Tin-x)